Experts in multiple myeloma discussed real-world efficacy and safety data associated with the use of GPRC5D-targeting bispecific agents to treat patients with R/R multiple myeloma. A panel of experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results